Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants.

Pediatric pulmonology(2023)

Cited 2|Views24
No score
Abstract
Standardization of CPGs may improve clinical decision making around use of palivizumab in high-risk infants.
More
Translated text
Key words
Palivizumab,RSV,guideline,infants,prophylaxis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined